WallStreetZenWallStreetZen

NASDAQ: RXRX
Recursion Pharmaceuticals Inc Stock Ownership - Who owns Recursion Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Recursion Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Christopher GibsonDirector2026-05-2240,000$3.08
$123.20kSell
Najat KhanCEO and President2026-05-1562,701$3.04
$190.61kSell
Ben R. TaylorChief Financial Officer2026-05-1525,018$3.04
$76.05kSell
David HallettChief Scientific Officer2026-05-1526,657$3.04
$81.04kSell
Christopher GibsonDirector2026-05-1522,821$3.04
$69.38kSell
Christopher GibsonDirector2026-05-0740,000$3.37
$134.80kSell
Blake BorgesonDirector2026-05-0530,000$3.52
$105.60kSell
Christopher GibsonDirector2026-04-2240,000$3.61
$144.40kSell
Christopher GibsonDirector2026-04-0740,000$3.10
$124.00kSell
Blake BorgesonDirector2026-04-0730,000$3.10
$93.00kSell

1 of 6

RXRX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when RXRX insiders and whales buy or sell their stock.

RXRX Shareholders

What type of owners hold Recursion Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Blackrock Inc8.15%43,192,306$148.58MInstitution
Ark Investment Management LLC7.59%40,212,769$138.33MInstitution
Lux Ventures IV LP5.72%30,308,614$104.26MInsider
State Street Corp5.38%28,490,638$98.01MInstitution
Baillie Gifford Co4.47%23,675,407$81.44MInstitution
Vanguard Portfolio Management LLC4.29%22,759,100$78.29MInstitution
Vanguard Capital Management LLC4.20%22,244,387$76.52MInstitution
Softbank Group Corp2.57%13,636,515$46.91MInstitution
Geode Capital Management LLC2.32%12,275,084$42.23MInstitution
MIC Capital Management Uk LLP1.82%9,644,032$33.18MInstitution

1 of 3

RXRX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
RXRX63.43%13.52%Net SellingNet Selling
RAPP77.56%22.44%Net SellingNet Selling
SRPT77.41%22.59%Net SellingNet Selling
ABCL40.70%44.04%Net BuyingNet Buying
STOK54.32%45.68%Net SellingNet Selling
View Top Biotech Stocks

Recursion Pharmaceuticals Stock Ownership FAQ

Who owns Recursion Pharmaceuticals?

Recursion Pharmaceuticals (NASDAQ: RXRX) is owned by 63.43% institutional shareholders, 13.52% Recursion Pharmaceuticals insiders, and 23.05% retail investors. Lux Ventures IV LP is the largest individual Recursion Pharmaceuticals shareholder, owning 30.31M shares representing 5.72% of the company. Lux Ventures IV LP's Recursion Pharmaceuticals shares are currently valued at $108.81M.

If you're new to stock investing, here's how to buy Recursion Pharmaceuticals stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.